PRF

Acadia Healthcare Reports Fourth Quarter 2023 Results

Retrieved on: 
Tuesday, February 27, 2024

Acadia Healthcare Company, Inc. (“Acadia” or the “Company”) (NASDAQ: ACHC) today announced financial results for the fourth quarter and year ended December 31, 2023.

Key Points: 
  • Acadia Healthcare Company, Inc. (“Acadia” or the “Company”) (NASDAQ: ACHC) today announced financial results for the fourth quarter and year ended December 31, 2023.
  • Chris Hunter, Chief Executive Officer of Acadia, remarked, “Our fourth quarter performance capped off another outstanding year for Acadia.
  • During the fourth quarter of 2023 and into the first quarter of 2024, the Company continued to make progress in meeting its strategic growth objectives with the following accomplishments across its five defined growth pathways:
    Facility Expansions – Added 98 beds to existing facilities in the fourth quarter, for a total of 302 new beds added in 2023.
  • Extend Continuum of Care – Expanded treatment options by adding 13 outpatient programs during the fourth quarter, bringing Acadia’s total to 39 outpatient programs added during 2023.

The Dr. Alexander Golberg Wellness Institute Introduces a New Holistic Approach to Pain Relief

Retrieved on: 
Friday, November 17, 2023

Platelet-Rich-Plasma (PRP) Injection for pain relief at The Dr. Golberg Wellness Institute.

Key Points: 
  • Platelet-Rich-Plasma (PRP) Injection for pain relief at The Dr. Golberg Wellness Institute.
  • Additionally, Dr. Golberg employs Platelet-Rich Fibrin (PRF) and Exosome Injections to further elevate his pain management approach.
  • By utilizing both therapies, Dr Golberg expedites the body's healing process and diminishes inflammation, offering supplementary pathways for relief.
  • The Dr. Golberg Wellness Institute's holistic approach has led to an array of success stories, improving the lives of countless individuals suffering with various forms of pain.

Iteld Plastic Surgery Launches New Aesthetics Website

Retrieved on: 
Tuesday, October 31, 2023

The Iteld Aesthetics Institute site, which launched this summer, includes detailed information on services such as PRP and PRF , PRF EZ Gel plasma filler, Sculptra® biostimulatory fillers , and microneedling with exosomes.

Key Points: 
  • The Iteld Aesthetics Institute site, which launched this summer, includes detailed information on services such as PRP and PRF , PRF EZ Gel plasma filler, Sculptra® biostimulatory fillers , and microneedling with exosomes.
  • Patients who are seeking other types of surgical and non-surgical cosmetic procedures can find more details on various options on the main Iteld Plastic Surgery website.
  • For more information on natural non-surgical skin rejuvenation treatments, contact Chicago’s Iteld Plastic Surgery.
  • Call (312) 757-4505, fill out a contact form to schedule a consultation, or visit the Iteld Aesthetics Institute site for more details.

Acadia Healthcare Reports Third Quarter 2023 Results and Updates Guidance Ranges to Reflect Continued Strong Business Growth and Momentum

Retrieved on: 
Thursday, November 2, 2023

Acadia Healthcare Company, Inc. (“Acadia”) (NASDAQ: ACHC) today announced financial results for the third quarter ended September 30, 2023.

Key Points: 
  • Acadia Healthcare Company, Inc. (“Acadia”) (NASDAQ: ACHC) today announced financial results for the third quarter ended September 30, 2023.
  • Chris Hunter, Chief Executive Officer of Acadia, remarked, “Our results for the third quarter reflect our continued execution on our growth strategy as well as strong operational execution across all four of our business lines.
  • “We produced strong financial results with impressive top line growth and favorable volume trends compared with the third quarter of 2022.
  • We expect the strategic technology investments we have made will further enhance our performance, drive efficiencies, and support strong clinical outcomes.

REGENATIVE LABS, TOGETHER WITH THE PAIN AND SLEEP THERAPY CENTER, PUBLISHES CASE STUDY DEMONSTRATING NEW CARE ADVANCEMENTS USING WHARTON'S JELLY ALLOGRAFTS IN TEMPOROMANDIBULAR JOINT DEFECTS

Retrieved on: 
Thursday, October 26, 2023

PENSACOLA, Fla., Oct. 26, 2023 /PRNewswire/ -- Regenative Labs (Regenative), a leading HCT/P manufacturer, announces the publication of a case study demonstrating new care advancements using its Wharton's Jelly allografts in the supplementation of Temporomandibular Joint (TMJ) defects. The case study titled "Single-Center Retrospective Study of Flowable Umbilical Cord Tissue Allograft Application in Temporomandibular Joint Defects: An Investigative Study," was published by Walsh Medical Media and can be accessed in its entirety here.

Key Points: 
  • PENSACOLA, Fla., Oct. 26, 2023 /PRNewswire/ -- Regenative Labs (Regenative), a leading HCT/P manufacturer, announces the publication of a case study demonstrating new care advancements using its Wharton's Jelly allografts in the supplementation of Temporomandibular Joint (TMJ) defects.
  • The case study titled "Single-Center Retrospective Study of Flowable Umbilical Cord Tissue Allograft Application in Temporomandibular Joint Defects: An Investigative Study," was published by Walsh Medical Media and can be accessed in its entirety here.
  • After one application of Regenative's Wharton's Jelly allograft, the patient's pain improved by an average of 75% after 90 days.
  • "A few years ago, we started using PRF (platelet-rich fibrin) therapy in the jaw joint, and we thought that was revolutionary.

Medallion Receives Notice of Default From Purdue Research Foundation

Retrieved on: 
Tuesday, October 10, 2023

VANCOUVER, British Columbia, Oct. 09, 2023 (GLOBE NEWSWIRE) -- Medallion Resources Ltd. (TSX-V: MDL; OTCQB: MLLOF; Frankfurt: MRDN) – “Medallion” or the “Company”) announced today that it has received notice of default from Purdue Research Foundation (“PRF”) and has until October 17, 2023 to cure the default or the Company’s license to use ligand assisted displacement chromatography will be terminated.

Key Points: 
  • VANCOUVER, British Columbia, Oct. 09, 2023 (GLOBE NEWSWIRE) -- Medallion Resources Ltd. (TSX-V: MDL; OTCQB: MLLOF; Frankfurt: MRDN) – “Medallion” or the “Company”) announced today that it has received notice of default from Purdue Research Foundation (“PRF”) and has until October 17, 2023 to cure the default or the Company’s license to use ligand assisted displacement chromatography will be terminated.
  • The Company is in discussion with PRF about curing the default or extending the term but there is no assurance that those discussions will be successful.

REGENATIVE LABS, TOGETHER WITH THE PAIN AND SLEEP THERAPY CENTER, ANNOUNCE NEW CARE ADVANCEMENTS USING WHARTON'S JELLY ALLOGRAFTS IN TEMPOROMANDIBULAR JOINT DEFECTS

Retrieved on: 
Tuesday, October 3, 2023

PENSACOLA, Fla., Oct. 3, 2023 /PRNewswire/ -- Regenative Labs (Regenative), a leading HCT/P manufacturer, announces a retrospective case series demonstrating new care advancements using its Wharton's Jelly allografts in the supplementation of Temporomandibular Joint (TMJ) defects.

Key Points: 
  • PENSACOLA, Fla., Oct. 3, 2023 /PRNewswire/ -- Regenative Labs (Regenative), a leading HCT/P manufacturer, announces a retrospective case series demonstrating new care advancements using its Wharton's Jelly allografts in the supplementation of Temporomandibular Joint (TMJ) defects.
  • Standard treatment includes simply resting the jaw muscles and avoiding use, massage, physical therapy, medication management, and, when all else fails, surgery.
  • After one application of Regenative's Wharton's Jelly allograft, the patient's pain improved by an average of 75% after 90 days.
  • "A few years ago, we started using PRF (platelet-rich fibrin) therapy in the jaw joint, and we thought that was revolutionary.

Global Timber Laminating Adhesives Market Expected to Reach $1,331 Million by 2028, Fueled by Sustainable Construction Trends in Europe - ResearchAndMarkets.com

Retrieved on: 
Tuesday, September 19, 2023

The timber laminating adhesives market is set to grow substantially, with a projected size of USD 1,331 million by 2028, showcasing a remarkable CAGR of 6.8% from USD 957 million in 2022.

Key Points: 
  • The timber laminating adhesives market is set to grow substantially, with a projected size of USD 1,331 million by 2028, showcasing a remarkable CAGR of 6.8% from USD 957 million in 2022.
  • Timber laminating adhesives play a pivotal role in modern construction, enabling the creation of engineered wood products that offer superior strength and versatility.
  • Timber laminating adhesives contribute to sustainable construction by facilitating the use of engineered wood products, optimizing wood utilization, and reducing construction projects' carbon footprint.
  • The rising demand for green building certifications, such as LEED (Leadership in Energy and Environmental Design), has further fueled the need for sustainable construction materials, including timber laminating adhesives.

Duke Energy honors eight organizations with 2023 Power Partner Awards

Retrieved on: 
Tuesday, August 29, 2023

Winners demonstrated excellence in sustainability, safety and community service

Key Points: 
  • Winners demonstrated excellence in sustainability, safety and community service
    CHARLOTTE, N.C., Aug. 29, 2023 /PRNewswire/ -- Duke Energy has chosen eight organizations to receive its 2023 Power Partner Award.
  • Evonik, a German based chemical company, partnered with Duke Energy to strengthen the safety culture at its Tippecanoe Laboratory site.
  • FujiFilm has also partnered with Duke Energy to provide backup generation to the site through a 15-year Premier Power agreement.
  • Duke Energy (NYSE: DUK), a Fortune 150 company headquartered in Charlotte, N.C., is one of America's largest energy holding companies.

Dr. Golberg Wellness Institute Introduces Advanced Skin Hyperpigmentation Treatment Using PRF, Exosomes and PDO Threads

Retrieved on: 
Thursday, August 24, 2023

New York, New York--(Newsfile Corp. - August 24, 2023) - Dr. Golberg Wellness Institute, a leader in non-surgical aesthetics, unveils a new skin hyperpigmentation treatment that promises long lasting and natural looking results.

Key Points: 
  • New York, New York--(Newsfile Corp. - August 24, 2023) - Dr. Golberg Wellness Institute, a leader in non-surgical aesthetics, unveils a new skin hyperpigmentation treatment that promises long lasting and natural looking results.
  • Developed by Dr. Alexander Golberg, this cutting-edge technique combines Platelet-Rich Fibrin (PRF), Exosomes, and Polydioxanone (PDO) threads, to provide a minimally invasive approach to address skin hyperpigmentation.
  • Dr. Golberg's innovative hyperpigmentation treatment combines repair-enriching molecules such as PRF, exosomes, and PDO threads.
  • Results from the skin hyperpigmentation treatment at the Dr. Golberg Wellness Institute
    The Dr. Golberg Wellness Institute is a leading centre for cutting-edge aesthetic and wellness solutions.